Trusted News Discovery Since 2008
{{/content}}
COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns grow
Credit: DNA- Published on January 19, 2021
Bharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country.
You are here
💡 newsR Knowledge: Other News Mentions
Coronavirus disease 2019
Disease caused by severe acute respiratory syndrome coronavirus 2
BBV152
Vaccine against COVID-19
A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company..
Credit: IndiaTimes - Published 3 days ago
The phase 3 results of Covaxin released on Wednesday showing 81% efficacy is seen by the government as a major validation of the scientific process and..
Credit: IndiaTimes - Published 3 days ago
Credit: IndiaTimes - Published 4 days ago
The trials for the third phase of the vaccine involved 25,800 subjects and it was the largest ever conducted in India.
Credit: DNA - Published 5 days ago
Bharat Biotech
Indian biotechnology company and vaccine manufacturer
"We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So..
Credit: IndiaTimes - Published 5 days ago
This interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical..
Credit: IndiaTimes - Published 5 days ago